Pharmaceutical Executive-08-01-2022

Pharma’s Training Transformation: COVID Forces Compliance Revamp, Re-education

August 10, 2022

Features

42

8

How one company in particular has adjusted its internal and customer-facing strategies in compliance training amid today’s heightened business-risk climate.

A Cross-Functional Formula: Operationalizing the Broader Role of Access

August 10, 2022

Features

42

8

The BCG Market Access Roundtable outlines the new and advanced access competencies required to enable functional operationalization and delivery of this critical role in biopharma—today a key strategic partner in achieving overall business goals.

The Potential of Proteomics

August 10, 2022

Features

42

8

Major stakeholders—including policymakers, public-private interests, and academia—are increasingly embracing the potential of proteomics technology in reshaping diagnostics and patient care.

Getting ‘Personal’ With Vaccine Development

August 10, 2022

Features

42

8

Innovative and continuous remote patient monitoring, along with AI-based predictive analytics, are advancing progress toward replacing the one-size-fits-all, population-driven vaccination model.

The Price of Innovation: ‘Paying for a Cure’ Remains Costly Proposition

August 10, 2022

Features

42

8

Curative-type therapies offer great hope in further transforming treatments for cancer and other diseases, but addressing the economics of these products—and ultimately the cost-benefit equation—is daunting. What is being done to smooth the path for pricing and reimbursement?

Milestones and Momentum: Assessing Advancements in Personalized Medicine

August 10, 2022

Features

42

8

The road to precision medicine as a fixture in healthcare delivery is still a journey, but recent advances and new understandings in gene profiling, biomarker development, and AI and data analytics are steadily bringing these therapies closer to the individual patient every day.

A World of Opportunity

August 10, 2022

Executive Profile

42

8

Marie-France Tschudin, president, innovative medicines international, and chief commercial officer at Novartis, taps into life lessons to help bring therapies to people in novel ways­.